Clinical contracts. Dr. Johan Wouterloot Prescribers Course April 28, 2017

Similar documents
Treatment Agreements Clinical Contracts. Dr. Paul A. Farnan, Dr. Johan Wouterloot Prescribers Course, Vancouver, BC, Canada October 13, 2017

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Prescription Monitoring Program (PMP)

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Ahsan U. Rashid, M.D., F.A.C.P.

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Nurse Practitioner Practice Guideline Treatment Agreements

Confirm Limit--Level of detectable drugs in urine to confirm a positive test.

Medication Agreements Promoting awareness, dialogue and level-set expectations

Methadone/ Suboxone Treatment in federal prison

COLLEGE OF PHYSICIANS AND SURGEONS OF NOVA SCOTIA SUMMARY OF DECISION OF INVESTIGATION COMMITTEE D. Dr. Deanna Swinamer

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Patient Agreement for the use of Opioid Medications

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

OPIOID PAIN MEDICATION Agreement and Informed Consent

For female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:

ISSUING AGENCY: Regulation and Licensing Department - NM Board of Osteopathic Medical Examiners.

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

TRIM reference DD17/ Endorsed by Publication date Review date

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

25/04/2017. To ensure that the Rx meets CPSS standards. To provide patient-centered, individualized care. To safely dispense the patient s medication

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Legal Issues in Opioid Prescribing

Prescription Drug Monitor Programs (PMDP): Combating prescription drug misuse and abuse. A physician s perspective.

Tracker e-prescribing 101. The Complete Guide

literature that drug combinations containing butalbital should not be used in treatment of chronic pain and are not appropriate for long term routine

PATIENT SIGNATURE: DOB: Date:

Workplace Drug and Alcohol Policy

Prescription Opioid Addiction

Principles and language suggestions for talking with patients

Drug and Alcohol Policy

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Managing the Drug-Free Workplace Quiz

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

Xanax help with opiate withdrawal

Appendix F Federation of State Medical Boards

DRUG TESTING FOR DISTRICT PERSONNEL REQUIRED TO HOLD A COMMERCIAL DRIVER S LICENSE

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

About Your Pain Management

DOUGLAS COUNTY GOVERNMENT POLICY FORM. To ensure a drug-free work environment within Douglas County Government.

4543 Project Titles 1

Opioids in the Management of Chronic Pain: An Overview

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

Service Level Agreement. for the Enhanced. Pharmaceutical Service. Administration of Medication. Between Turning Point &

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Drugs. January 30, , 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458

2004-L SEPTEMBER

E. "Prospective employee": A person who has made application, whether written or oral, to CWI to become an employee.

Syracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information

The Difficult Patient: Risk Mitigation Strategies

Triage, Assessment and Treatment Planning

Policy Title. Control Number HR003. Exception The Scotland County Sheriff s Department is subject to a separate policy.

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Health Care 3: Partnering In My Care and Treatment

Medicare Part D Opioid Policies for 2019 Information for Patients

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Opiate Use among Ohio Medicaid Recipients

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Kenosha County Drug and Alcohol Abuse Policy

Drugs and Alcohol Abuse Policy

Prescribing and Dispensing Drugs

Workplace Drug and Alcohol Policy

Do not open the test booklet prior to being told to do so.

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

About Your Pain Management

Alcohol & Drug Practice

Disease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Buprenorphine Patient Education

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

THERAPEUTIC CONSIDERATIONS OF PSYCHOPHARMACOLOGY OF OPIATE USE DISORDER. Presenter: Linda Shaffer MA, Ed.S., LCAS, MAC

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Opioid Review and MAT Clinic CDC Guidelines

NEWBERRY COUNTY EMERGENCY SERVICES SUBSTANCE ABUSE POLICY

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017

How much codeine to be addicted

DRUG FREE WORKPLACE POLICY

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

METHYLPHENIDATE AND ATOMOXETINE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND YOUNG PEOPLE

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Script for audio: Pseudoephedrine and ephedrine. Audiovisual training for pharmacy support staff

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

Welcome - we will begin the webinar shortly Please read the participation tips below:

Prescription Opioids

Opioid Focus Group Summaries

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Transcription:

Clinical contracts Dr. Johan Wouterloot Prescribers Course April 28, 2017

Why? Ameliorates power imbalance States a goal for the agreed upon activity Allows for contingency management to keep behaviour within safe and acceptable limits Prevents acceleration of medication use Allows monitoring and describes its use Provides documentation that safe limits have been established

Types of contracts Prescribing agreements Weaning agreements Monitoring agreements

Prescribing agreements Mandatory if narcotics prescribed Should include any long term narcotic prescriptions, including T#3 s Discuss OTC narcotics as well Strongly advised for benzodiazepines, Z drugs, stimulants Modify the narcotics agreement Other medications if a Hx of substance use is present (gabapentin, cyclobenzaprine, bupropion) Not necessary for acute pain relief, unless Hx of substance use

Weaning agreements Very difficult to enforce, with frequent bargaining due to the intrusion of adverse life events Easy to become derailed Therefore the initial detailed discussion of weaning schedule and agreement of this is critical and allows the schedule to remain on track (e.g. 10 % reduction in benzodiazepine dosage per month is the standard) exceeding this rate in a hurried response to escape a situation will result in bargaining and pressure to modify the agreement

Monitoring agreements PharmaNet have every patient sign on first encounter and include all names of clinic physicians on each contract Advise that a pharmanet search will precede every prescription of a potentially addictive medication Requests for random UDS, pill callbacks are usually embedded in prescribing agreements

Initiating the agreement Review the goal (e.g. improved function, not pain relief with narcotics) and review the time line of the agreement (esp for weaning agreements) Do not be in a hurry Outline a schedule of appointments, prescribing elements and contingency consequences and frequency of monitoring Outline the significant clauses and have patient initial them may wish to have patient repeat clause in their own words

Initiating continued Outline a schedule of appointments, prescribing elements, contingency consequences and colleagues Have client choose one drug store and create working relationship with pharmacist Advise patient that pharmacist reports will be believed and acted upon Notify other prescribers (notify again if duplicate prescribing continues) Give patient a copy of the agreement Have agreement readily available in chart

Ensuring adherence

Step 1 Track one s own prescribing Avoid prn doses change to regular dosing Calculate the amounts prescribed in weeks (months and 100 day amounts are too vague to follow accurately) Document start date and end date (remember that a week s prescription which starts on Wednesday will end on a Tuesday) Also document dispensing schedule on prescription Advise patient to make a return appointment before they leave the office (avoids the crisis of not being able to get an appointment on the day that the pills are finished)

Step 2 the levers available Prescribing in the first place (not ethical to refuse patient care in other matters due to a voided prescribing contract) Appointment frequency (missed appointment is a contract violation) and length of prescription Dispensing frequency Colleagues expected to impose DWI/daily dispensing if bridge dosing Dose Monitoring frequency

Step 3 At each contract violation, a new response is necessary Temporary action is preferred if violations are infrequent, minor and the patient appears teachable Consequences may have to be longer/permanent if repeated violations, loss of trust or threat to patient safety Ensure pharmacy is aware of your policy re: violations Consequences need to be permanent if monitoring unable to detect the problem

The Art of Enforcing contracts Base response on safety, patient understanding and regard for spirit of contract Inappropriate severe consequences can be as unsafe as having no boundaries on prescribing (precipitated withdrawal, use of illegal substances, IDU, loss of physician-patient relationship) A modulated approach to consequences will be easier for the physician to enforce and will be more palatable to the patient Caveat is safety if there is a substantial risk, then greater measures must be taken immediately But every contract violation needs a response

When resistance occurs Roll with it and don t push back Frame re: safety Ally with patient against problem Speak in the theoretical

Before the appointment with client Know the prescribing boundaries State the boundary immediately and then have discussion Practice enforcement phrases or responses Avoid fatigue If a pattern of inappropriate prescribing already exists, schedule extra time and state the new conditions do not let time considerations force you into an expedient decision

Monitoring PharmaNet check before writing any prescription for narcotics, sedatives, stimulants or any other medication suspected of abuse E.g. gabapentin, buprenorphine, cyclobenzaprine, quetiapine, trazodone, etc. If inappropriate third party prescribing occurs, notify prescriber and warn patient If continues, then wean or terminate prescribing

Monitoring - UDS Point of care UDS both at appointments and random call backs Allow 2 days can sit in fridge over W/E Laboratory collections are stricter and often unsettling (patients treated differently when submitting UDS) r/o forced UDS creat > 20, SG > 1.002, no adulterants, temperature > 34 Need to see prescribed substance and no other substance If unclear, send to laboratory for LC/MS confirmation

POC UDS Financially viable 15040 ($12.40) Interpretation can be complex False positives common for amphetamines Only chlordiazepoxide, diazepam, oxazepam, temazepam expected on BZP screen Only codeine, morphine and heroin seen on opiate screen + ve for 2-3 days after occl use and +ve for 30 days after continuous use

Monitoring Random pill call back counts Be able to recognize tablet know which store patient uses and have store send a photo of the tablet/capsule dispensed Appointment adherence often a marker to adherence in other areas Have a policy for called in appointments written into contract Both for random UDS and pill count callbacks, it is the patient s responsibility to keep contact information and drugstore information up to date inability to contact cannot be used as an excuse to avoid contingency consequences

Special situations Hospitalization s/w hospitalist/mrp Travel Sent script to destination drug store If out of province, ask to see travel documents

Things change over time